Article PDF first page preview

First page of Circulating cell-free tumor DNA-Based Liquid Biopsy of Cerebrospinal Fluid in retinoblastoma

Introduction: Monitoring central nervous system (CNS) involvement in retinoblastoma traditionally relies on Cerebrospinal fluid (CSF) cytology and MRI imaging. This study assesses the usefulness of CSF liquid biopsy as a modality for detection of early CNS dissemination and prognostication in retinoblastoma patients. Methods: Patients with stage 3 unilateral non-germline retinoblastoma were included in this study. CSF, blood and tumor tissue (wherever available), were collected from the participants forming two distinct groups based on sample pairing: "paired CSF and tumor, and "paired CSF and blood". CSF collection by spinal tap was done as part of the metastatic workup protocol for all extraocular retinoblastoma patients. Cell free DNA(cfDNA) was isolated for subsequent RB1 mutation analysis by targeted next generation sequencing (NGS). Results: CSF cytology yielded no atypical cells in all cases. Targeted NGS data of cfDNA isolated from CSF revealed RB1 mutated cfDNA in the CSF of 6 out of 11 ( 54.5%)patients. All 6 patients with detectable RB1 mutations in CSF developed symptoms of CNS involvement and succumbed to the disease on subsequent followup. 4 out of 5( 80%)patients where RB1 mutated cell-free tumor DNA was not detected in CSF, are currently alive with no evidence of CNS disease at a mean follow up of 20 months(range 10-26 months). Conclusions: CSF liquid biopsy can serve as early diagnosis modality for minimally disseminated CNS disease. Further investigations involving larger cohorts are imperative to validate these findings robustly and ascertain the clinical utility of CSF liquid biopsy in routine practice for retinoblastoma patients.

Journal Section:
Clinical Research
This content is only available via PDF.
S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.